Page 63 - TD-4-3

Tumor Discovery Prognostication in palliative cancer care

cancer. Cancer Treat Rev. 2013;39(5):534-540. 28. Hui D, Park M, Shamieh O, et al. Personalized symptom
goals and response in patients with advanced cancer. Cancer.
doi: 10.1016/j.ctrv.2012.08.003
2016;122(11):1774-1781.
19. Forrest LM, McMillan DC, McArdle CS, Angerson WJ,
Dunlop DJ. Comparison of an inflammation-based doi: 10.1002/cncr.29970
prognostic score (GPS) with performance status (ECOG) 29. Geijteman ECT, Kuip EJM, Oskam J, Lees D,
in patients receiving platinum-based chemotherapy Bruera E. Illness trajectories of incurable solid cancers. BMJ.
for inoperable non-small-cell lung cancer. Br J Cancer. 2024;384:e076625.
2004;90(9):1704-1706. doi: 10.1136/bmj-2023-076625
doi: 10.1038/sj.bjc.6601789 30. Casarett D. The median is not the (only) message. Ann
20. Nozoe T, Iguchi T, Egashira A, Adachi E, Matsukuma A, Intern Med. 2006;145(9):700-701.
Ezaki T. Significance of modified Glasgow prognostic score doi: 10.7326/0003-4819-145-9-200611070-00014
as a useful indicator for prognosis of patients with gastric
carcinoma. Am J Surg. 2011;201(2):186-191. 31. Hemingway H, Croft P, Perel P, et al. Prognosis research
strategy (PROGRESS) 1: A framework for researching
doi: 10.1016/j.amjsurg.2010.01.03 clinical outcomes. BMJ. 2013;346:e5595.
21. Hu X, Wang Y, Yang WX, Dou WC, Shao YX, Li X. Modified doi: 10.1136/bmj.e5595
Glasgow prognostic score as a prognostic factor for renal cell
carcinomas: A systematic review and meta-analysis. Cancer 32. Trevethan R. Sensitivity, specificity, and predictive values:
Manag Res. 2019;11:6163-6173. Foundations, pliabilities, and pitfalls in research and
practice. Front Public Health. 2017;5:307.
doi: 10.2147/CMAR.S208839
doi: 10.3389/fpubh.2017.00307
22. Shimada A, Matsuda T, Sawada R, et al. The modified
Glasgow prognostic score is a reliable predictor of oncological 33. Thronaes M, Lohre ET, Kvikstad A, et al. Interventions and
outcomes in patients with rectal cancer undergoing symptom relief in hospital palliative cancer care: Results
neoadjuvant chemoradiotherapy. Sci Rep. 2023;13(1):17111. from a prospective longitudinal study. Support Care Cancer.
2021;29(11):6595-6603.
doi: 10.1038/s41598-023-44431-w
doi: 10.1007/s00520-021-06248-z
23. Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors
in advanced cancer patients: Evidence-based clinical 34. Talari K, Goyal M. Retrospective studies - utility and caveats.
recommendations--a study by the steering committee of J R Coll Physicians Edinb. 2020;50(4):398-402.
the European association for palliative care. J Clin Oncol. doi: 10.4997/JRCPE.2020.409
2005;23(25):6240-6248.
35. Doll R, Hill AB. Smoking and carcinoma of the lung;
doi: 10.1200/JCO.2005.06.866 Preliminary report. Br Med J. 1950;2(4682):739-748.
24. Stone P, Vickerstaff V, Kalpakidou A, et al. Prognostic tools doi: 10.1136/bmj.2.4682.739
or clinical predictions: Which are better in palliative care?
PLoS One. 2021;16(4):e0249763. 36. Cheng HG, Phillips MR. Secondary analysis of existing
data: Opportunities and implementation. Shanghai Arch
doi: 10.1371/journal.pone.0249763 Psychiatry. 2014;26(6):371-375.
25. Mori M, Morita T, Bruera E, Hui D. Prognostication of the doi: 10.11919/j.issn.1002-0829.214171
last days of life. Cancer Res Treat. 2022;54(3):631-643.
37. Hackshaw A. Small studies: Strengths and limitations. Eur
doi: 10.4143/crt.2021.1573 Respir J. 2008;32(5):1141-1143.
26. Oldenmenger WH, De Raaf PJ, De Klerk C, Van Der doi: 10.1183/09031936.00136408
Rijt CC. Cut points on 0-10 numeric rating scales for
symptoms included in the Edmonton symptom assessment 38. Ross PT, Bibler Zaidi NL. Limited by our limitations.
scale in cancer patients: A systematic review. J Pain Symptom Perspect Med Educ. 2019;8(4):261-264.
Manage. 2013;45(6):1083-1093. doi: 10.1007/s40037-019-00530-x
doi: 10.1016/j.jpainsymman.2012.06.007 39. Norton BJ, Strube MJ. Understanding statistical power.
J Orthop Sports Phys Ther. 2001;31(6):307-315.
27. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR,
Cleeland CS. When is cancer pain mild, moderate or severe? doi: 10.2519/jospt.2001.31.6.307
Grading pain severity by its interference with function. Pain. 40. Laird BJ, Kaasa S, McMillan DC, et al. Prognostic factors
1995;61(2):277-284.
in patients with advanced cancer: A comparison of
doi: 10.1016/0304-3959(94)00178-H clinicopathological factors and the development of an

Volume 4 Issue 3 (2025) 55 doi: 10.36922/td.8576